www.buy-trusted-tablets.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Lamivudine zidovudine - Combivir, Epivir, Retrovir
Combivir Online
Lamivudine - Zidovudine 150mg + 300mg
Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
€1.30
Buy now!
Epivir Online
Generic Epivir is used for treating HIV infection in combination with other medicines.
€1.56
Buy now!
Retrovir Online
Generic Retrovir is used for treating HIV infection when used along with other medicines. It is also used with other medicines to help prevent women from passing the HIV virus to the fetus during pregnancy.
€1.05
Buy now!
Choose Your language:
- Testimonials
-
thanks for the great job getting my medication to me. Your product is the same quality I was getting in the local pharmacy but your pricing has help me to better afford my medication. - JAMES
Read more »
-
- This RSS feed URL is deprecated
- This RSS feed URL is deprecated, please update
- Landmark Phase III studies for dolutegravir and lamivudine - The Pharma Letter
- The Pharma LetterLandmark Phase III studies for dolutegravir and lamivudineThe Pharma LetterViiV Healthcare, the specialty HIV/AIDS company majority owned by GlaxoSmithKline (LSE: GSK), today announced positive headline results from its Phase III GEMINI study program
- ViiV has 'another formidable asset' in rivalry with Gilead - The Pharma Letter
- The Pharma LetterViiV has 'another formidable asset' in rivalry with GileadThe Pharma LetterClaims by ViiV Healthcare's chief executive Deborah Waterhouse (pictured above) that her company is doing more than just playing second fiddle to US biotech Gilead Science (Nasdaq: GILD) in the HIV space have been backed up by an analyst at
- ViiV adds to case for two-drug HIV regimen - The Pharma Letter
- The Pharma LetterViiV adds to case for two-drug HIV regimenThe Pharma LetterIn its attempts to show the effectiveness of using two drug combinations in HIV, ViiV Healthcare has added more data to its evidence base
- Antiretroviral Contraindications and Drug Interactions - Infectious Disease Advisor
- Antiretroviral Contraindications and Drug InteractionsInfectious Disease AdvisorSevere renal impairment or ESRD (CrCl
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
